Loading…
Screening platelet function in blood donors
Background Transfusion of defective platelets could contribute to the inefficiency of platelet transfusion in preventing or stopping bleeding. Study Design and Methods This single‐center prospective study aimed to determine the prevalence of functional platelet abnormalities in a population of blood...
Saved in:
Published in: | Transfusion (Philadelphia, Pa.) Pa.), 2022-08, Vol.62 (8), p.1643-1651 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043 |
---|---|
cites | cdi_FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043 |
container_end_page | 1651 |
container_issue | 8 |
container_start_page | 1643 |
container_title | Transfusion (Philadelphia, Pa.) |
container_volume | 62 |
creator | Pedini, Pascal Baudey, Jean‐Baptiste Pouymayou, Katia Falaise, Celine Ibrahim‐Kosta, Manal Vélier, Melanie Demerle, Clémence Graiet, Hajer Dragutini, Catherine Dombey, Anne‐marie Chiaroni, Jacques Alessi, Marie Christine Picard, Christophe |
description | Background
Transfusion of defective platelets could contribute to the inefficiency of platelet transfusion in preventing or stopping bleeding.
Study Design and Methods
This single‐center prospective study aimed to determine the prevalence of functional platelet abnormalities in a population of blood donors with a clinical history of bleeding diathesis or with history of hematoma (>4 cm) during blood donation. Donors with positive bleeding screening questionnaire were referred to the reference center for rare platelet diseases at La Timone University Hospital (Marseille) to confirm the bleeding tendency using a more extensive bleeding questionnaire (MCMDMscore) and to assess hemostasis, including a comprehensive platelet analysis.
Results
One hundred and ninety‐five donors identified based on a history of hematoma and 2434 blood donors were included in the study. Eighty‐eight donors (3.6%) had a bleeding score indicating a potential bleeding disorder. Five donors with a history of hematoma (2.5%) and 15 (17%) donors with a confirmed bleeding score underwent hemostatic analysis, including two men and 18 women with average age of 33.9 years. Minor hemostatic abnormalities were observed in three donors. Two donors exhibited accelerated fibrinolysis with reduced euglobulin lysis time and increased D‐dimer levels in serum. Two donors had a platelet granule defect, without identification of genetic abnormality.
Conclusion
The bleeding questionnaire proved to be a valuable tool to screen blood donors for potential platelet defects. Platelet dysfunction was rare in the blood donor population assessed. Additional studies are necessary to understand the clinical impact that the transfusion of platelets with qualitative defects has on recipients. |
doi_str_mv | 10.1111/trf.16990 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03705360v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2681035313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043</originalsourceid><addsrcrecordid>eNp10E1LAzEQBuAgiq3Vg_9gwYsi206-dpujFGuFgqD1HNJNVrekSU12lf57UysKgrkMhGeSmRehcwxDnM6oDfUQF0LAAepjTsucCMEPUR-A4RxjSnroJMYVABAB-Bj1KC_ZmBekj66fqmCMa9xLtrGqNda0Wd25qm28yxqXLa33OtPe-RBP0VGtbDRn33WAnqe3i8ksnz_c3U9u5nlF0ww5rwgTNTBVMW2wZqwgmgmilOKs0jBWQjBVagwlY7UWjJoSF2xpxFInDYwO0NX-3Vdl5SY0axW20qtGzm7mcncHtAROC3jHyV7u7Sb4t87EVq6bWBlrlTO-i5IUYwyUU0wTvfhDV74LLm2SlBCYChDk9_Mq-BiDqX8mwCB3acuUtvxKO9nR3n401mz_h3LxON13fAITOHvm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2699139092</pqid></control><display><type>article</type><title>Screening platelet function in blood donors</title><source>Wiley</source><creator>Pedini, Pascal ; Baudey, Jean‐Baptiste ; Pouymayou, Katia ; Falaise, Celine ; Ibrahim‐Kosta, Manal ; Vélier, Melanie ; Demerle, Clémence ; Graiet, Hajer ; Dragutini, Catherine ; Dombey, Anne‐marie ; Chiaroni, Jacques ; Alessi, Marie Christine ; Picard, Christophe</creator><creatorcontrib>Pedini, Pascal ; Baudey, Jean‐Baptiste ; Pouymayou, Katia ; Falaise, Celine ; Ibrahim‐Kosta, Manal ; Vélier, Melanie ; Demerle, Clémence ; Graiet, Hajer ; Dragutini, Catherine ; Dombey, Anne‐marie ; Chiaroni, Jacques ; Alessi, Marie Christine ; Picard, Christophe</creatorcontrib><description>Background
Transfusion of defective platelets could contribute to the inefficiency of platelet transfusion in preventing or stopping bleeding.
Study Design and Methods
This single‐center prospective study aimed to determine the prevalence of functional platelet abnormalities in a population of blood donors with a clinical history of bleeding diathesis or with history of hematoma (>4 cm) during blood donation. Donors with positive bleeding screening questionnaire were referred to the reference center for rare platelet diseases at La Timone University Hospital (Marseille) to confirm the bleeding tendency using a more extensive bleeding questionnaire (MCMDMscore) and to assess hemostasis, including a comprehensive platelet analysis.
Results
One hundred and ninety‐five donors identified based on a history of hematoma and 2434 blood donors were included in the study. Eighty‐eight donors (3.6%) had a bleeding score indicating a potential bleeding disorder. Five donors with a history of hematoma (2.5%) and 15 (17%) donors with a confirmed bleeding score underwent hemostatic analysis, including two men and 18 women with average age of 33.9 years. Minor hemostatic abnormalities were observed in three donors. Two donors exhibited accelerated fibrinolysis with reduced euglobulin lysis time and increased D‐dimer levels in serum. Two donors had a platelet granule defect, without identification of genetic abnormality.
Conclusion
The bleeding questionnaire proved to be a valuable tool to screen blood donors for potential platelet defects. Platelet dysfunction was rare in the blood donor population assessed. Additional studies are necessary to understand the clinical impact that the transfusion of platelets with qualitative defects has on recipients.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/trf.16990</identifier><identifier>PMID: 35748562</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Abnormalities ; Bleeding ; Blood ; Blood & organ donations ; blood donor ; Blood donors ; Blood platelets ; Blood transfusion ; Defects ; Fibrinolysis ; Hematoma ; Hemostasis ; hemostatic disorder ; Hemostatics ; Life Sciences ; Lysis ; platelet ; Platelets ; Population studies ; prevalence ; Questionnaires ; Screening ; Transfusion</subject><ispartof>Transfusion (Philadelphia, Pa.), 2022-08, Vol.62 (8), p.1643-1651</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of AABB.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043</citedby><cites>FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043</cites><orcidid>0000-0001-9299-3705 ; 0000-0002-3133-8990</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://hal.science/hal-03705360$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pedini, Pascal</creatorcontrib><creatorcontrib>Baudey, Jean‐Baptiste</creatorcontrib><creatorcontrib>Pouymayou, Katia</creatorcontrib><creatorcontrib>Falaise, Celine</creatorcontrib><creatorcontrib>Ibrahim‐Kosta, Manal</creatorcontrib><creatorcontrib>Vélier, Melanie</creatorcontrib><creatorcontrib>Demerle, Clémence</creatorcontrib><creatorcontrib>Graiet, Hajer</creatorcontrib><creatorcontrib>Dragutini, Catherine</creatorcontrib><creatorcontrib>Dombey, Anne‐marie</creatorcontrib><creatorcontrib>Chiaroni, Jacques</creatorcontrib><creatorcontrib>Alessi, Marie Christine</creatorcontrib><creatorcontrib>Picard, Christophe</creatorcontrib><title>Screening platelet function in blood donors</title><title>Transfusion (Philadelphia, Pa.)</title><description>Background
Transfusion of defective platelets could contribute to the inefficiency of platelet transfusion in preventing or stopping bleeding.
Study Design and Methods
This single‐center prospective study aimed to determine the prevalence of functional platelet abnormalities in a population of blood donors with a clinical history of bleeding diathesis or with history of hematoma (>4 cm) during blood donation. Donors with positive bleeding screening questionnaire were referred to the reference center for rare platelet diseases at La Timone University Hospital (Marseille) to confirm the bleeding tendency using a more extensive bleeding questionnaire (MCMDMscore) and to assess hemostasis, including a comprehensive platelet analysis.
Results
One hundred and ninety‐five donors identified based on a history of hematoma and 2434 blood donors were included in the study. Eighty‐eight donors (3.6%) had a bleeding score indicating a potential bleeding disorder. Five donors with a history of hematoma (2.5%) and 15 (17%) donors with a confirmed bleeding score underwent hemostatic analysis, including two men and 18 women with average age of 33.9 years. Minor hemostatic abnormalities were observed in three donors. Two donors exhibited accelerated fibrinolysis with reduced euglobulin lysis time and increased D‐dimer levels in serum. Two donors had a platelet granule defect, without identification of genetic abnormality.
Conclusion
The bleeding questionnaire proved to be a valuable tool to screen blood donors for potential platelet defects. Platelet dysfunction was rare in the blood donor population assessed. Additional studies are necessary to understand the clinical impact that the transfusion of platelets with qualitative defects has on recipients.</description><subject>Abnormalities</subject><subject>Bleeding</subject><subject>Blood</subject><subject>Blood & organ donations</subject><subject>blood donor</subject><subject>Blood donors</subject><subject>Blood platelets</subject><subject>Blood transfusion</subject><subject>Defects</subject><subject>Fibrinolysis</subject><subject>Hematoma</subject><subject>Hemostasis</subject><subject>hemostatic disorder</subject><subject>Hemostatics</subject><subject>Life Sciences</subject><subject>Lysis</subject><subject>platelet</subject><subject>Platelets</subject><subject>Population studies</subject><subject>prevalence</subject><subject>Questionnaires</subject><subject>Screening</subject><subject>Transfusion</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp10E1LAzEQBuAgiq3Vg_9gwYsi206-dpujFGuFgqD1HNJNVrekSU12lf57UysKgrkMhGeSmRehcwxDnM6oDfUQF0LAAepjTsucCMEPUR-A4RxjSnroJMYVABAB-Bj1KC_ZmBekj66fqmCMa9xLtrGqNda0Wd25qm28yxqXLa33OtPe-RBP0VGtbDRn33WAnqe3i8ksnz_c3U9u5nlF0ww5rwgTNTBVMW2wZqwgmgmilOKs0jBWQjBVagwlY7UWjJoSF2xpxFInDYwO0NX-3Vdl5SY0axW20qtGzm7mcncHtAROC3jHyV7u7Sb4t87EVq6bWBlrlTO-i5IUYwyUU0wTvfhDV74LLm2SlBCYChDk9_Mq-BiDqX8mwCB3acuUtvxKO9nR3n401mz_h3LxON13fAITOHvm</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Pedini, Pascal</creator><creator>Baudey, Jean‐Baptiste</creator><creator>Pouymayou, Katia</creator><creator>Falaise, Celine</creator><creator>Ibrahim‐Kosta, Manal</creator><creator>Vélier, Melanie</creator><creator>Demerle, Clémence</creator><creator>Graiet, Hajer</creator><creator>Dragutini, Catherine</creator><creator>Dombey, Anne‐marie</creator><creator>Chiaroni, Jacques</creator><creator>Alessi, Marie Christine</creator><creator>Picard, Christophe</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-9299-3705</orcidid><orcidid>https://orcid.org/0000-0002-3133-8990</orcidid></search><sort><creationdate>202208</creationdate><title>Screening platelet function in blood donors</title><author>Pedini, Pascal ; Baudey, Jean‐Baptiste ; Pouymayou, Katia ; Falaise, Celine ; Ibrahim‐Kosta, Manal ; Vélier, Melanie ; Demerle, Clémence ; Graiet, Hajer ; Dragutini, Catherine ; Dombey, Anne‐marie ; Chiaroni, Jacques ; Alessi, Marie Christine ; Picard, Christophe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abnormalities</topic><topic>Bleeding</topic><topic>Blood</topic><topic>Blood & organ donations</topic><topic>blood donor</topic><topic>Blood donors</topic><topic>Blood platelets</topic><topic>Blood transfusion</topic><topic>Defects</topic><topic>Fibrinolysis</topic><topic>Hematoma</topic><topic>Hemostasis</topic><topic>hemostatic disorder</topic><topic>Hemostatics</topic><topic>Life Sciences</topic><topic>Lysis</topic><topic>platelet</topic><topic>Platelets</topic><topic>Population studies</topic><topic>prevalence</topic><topic>Questionnaires</topic><topic>Screening</topic><topic>Transfusion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pedini, Pascal</creatorcontrib><creatorcontrib>Baudey, Jean‐Baptiste</creatorcontrib><creatorcontrib>Pouymayou, Katia</creatorcontrib><creatorcontrib>Falaise, Celine</creatorcontrib><creatorcontrib>Ibrahim‐Kosta, Manal</creatorcontrib><creatorcontrib>Vélier, Melanie</creatorcontrib><creatorcontrib>Demerle, Clémence</creatorcontrib><creatorcontrib>Graiet, Hajer</creatorcontrib><creatorcontrib>Dragutini, Catherine</creatorcontrib><creatorcontrib>Dombey, Anne‐marie</creatorcontrib><creatorcontrib>Chiaroni, Jacques</creatorcontrib><creatorcontrib>Alessi, Marie Christine</creatorcontrib><creatorcontrib>Picard, Christophe</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pedini, Pascal</au><au>Baudey, Jean‐Baptiste</au><au>Pouymayou, Katia</au><au>Falaise, Celine</au><au>Ibrahim‐Kosta, Manal</au><au>Vélier, Melanie</au><au>Demerle, Clémence</au><au>Graiet, Hajer</au><au>Dragutini, Catherine</au><au>Dombey, Anne‐marie</au><au>Chiaroni, Jacques</au><au>Alessi, Marie Christine</au><au>Picard, Christophe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening platelet function in blood donors</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><date>2022-08</date><risdate>2022</risdate><volume>62</volume><issue>8</issue><spage>1643</spage><epage>1651</epage><pages>1643-1651</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><abstract>Background
Transfusion of defective platelets could contribute to the inefficiency of platelet transfusion in preventing or stopping bleeding.
Study Design and Methods
This single‐center prospective study aimed to determine the prevalence of functional platelet abnormalities in a population of blood donors with a clinical history of bleeding diathesis or with history of hematoma (>4 cm) during blood donation. Donors with positive bleeding screening questionnaire were referred to the reference center for rare platelet diseases at La Timone University Hospital (Marseille) to confirm the bleeding tendency using a more extensive bleeding questionnaire (MCMDMscore) and to assess hemostasis, including a comprehensive platelet analysis.
Results
One hundred and ninety‐five donors identified based on a history of hematoma and 2434 blood donors were included in the study. Eighty‐eight donors (3.6%) had a bleeding score indicating a potential bleeding disorder. Five donors with a history of hematoma (2.5%) and 15 (17%) donors with a confirmed bleeding score underwent hemostatic analysis, including two men and 18 women with average age of 33.9 years. Minor hemostatic abnormalities were observed in three donors. Two donors exhibited accelerated fibrinolysis with reduced euglobulin lysis time and increased D‐dimer levels in serum. Two donors had a platelet granule defect, without identification of genetic abnormality.
Conclusion
The bleeding questionnaire proved to be a valuable tool to screen blood donors for potential platelet defects. Platelet dysfunction was rare in the blood donor population assessed. Additional studies are necessary to understand the clinical impact that the transfusion of platelets with qualitative defects has on recipients.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>35748562</pmid><doi>10.1111/trf.16990</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9299-3705</orcidid><orcidid>https://orcid.org/0000-0002-3133-8990</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1132 |
ispartof | Transfusion (Philadelphia, Pa.), 2022-08, Vol.62 (8), p.1643-1651 |
issn | 0041-1132 1537-2995 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03705360v1 |
source | Wiley |
subjects | Abnormalities Bleeding Blood Blood & organ donations blood donor Blood donors Blood platelets Blood transfusion Defects Fibrinolysis Hematoma Hemostasis hemostatic disorder Hemostatics Life Sciences Lysis platelet Platelets Population studies prevalence Questionnaires Screening Transfusion |
title | Screening platelet function in blood donors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A07%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20platelet%20function%20in%20blood%20donors&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Pedini,%20Pascal&rft.date=2022-08&rft.volume=62&rft.issue=8&rft.spage=1643&rft.epage=1651&rft.pages=1643-1651&rft.issn=0041-1132&rft.eissn=1537-2995&rft_id=info:doi/10.1111/trf.16990&rft_dat=%3Cproquest_hal_p%3E2681035313%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3990-5c249f04ac4de1d4462d492aaa54cd08a994a7d10744fd943e7164be9bd1d4043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2699139092&rft_id=info:pmid/35748562&rfr_iscdi=true |